430 related articles for article (PubMed ID: 32883931)
21. High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.
Riley TV; Collins DA; Karunakaran R; Kahar MA; Adnan A; Hassan SA; Zainul NH; Rustam FRM; Wahab ZA; Ramli R; Lee YY; Hassan H
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563206
[TBL] [Abstract][Full Text] [Related]
22. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
Jon J V; Mark H W; Jane F
Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
[TBL] [Abstract][Full Text] [Related]
24. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile infections in a university hospital in Greece are mainly associated with PCR ribotypes 017 and 126.
Kachrimanidou M; Tsachouridou O; Ziogas IA; Christaki E; Protonotariou E; Metallidis S; Skoura L; Kuijper E
J Med Microbiol; 2017 Dec; 66(12):1774-1781. PubMed ID: 29087273
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes.
Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M
Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology and antimicrobial resistance in Clostridioides difficile strains isolated from children and adolescents in a tertiary referral pediatric hospital in Fortaleza, Brazil.
Nogueira HBR; Costa CL; Quesada-Gómez C; Pacífico DM; Ferreira EO; Leitão RFC; Brito GAC
Braz J Infect Dis; 2024; 28(3):103767. PubMed ID: 38843868
[TBL] [Abstract][Full Text] [Related]
29. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
[TBL] [Abstract][Full Text] [Related]
30. The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
Krutova M; Capek V; Nycova E; Vojackova S; Balejova M; Geigerova L; Tejkalova R; Havlinova L; Vagnerova I; Cermak P; Ryskova L; Jezek P; Zamazalova D; Vesela D; Kucharova A; Nemcova D; Curdova M; Nyc O; Drevinek P
Antimicrob Resist Infect Control; 2020 Jun; 9(1):98. PubMed ID: 32605598
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
33. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019.
Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E
Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364
[TBL] [Abstract][Full Text] [Related]
34. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM
Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile infection in an Iranian hospital.
Jalali M; Khorvash F; Warriner K; Weese JS
BMC Res Notes; 2012 Mar; 5():159. PubMed ID: 22436392
[TBL] [Abstract][Full Text] [Related]
36. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
Russello G; Russo A; Sisto F; Scaltrito MM; Farina C
New Microbiol; 2012 Jul; 35(3):307-16. PubMed ID: 22842600
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC
PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266
[TBL] [Abstract][Full Text] [Related]
39. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.
Gerding DN; Johnson S; Rupnik M; Aktories K
Gut Microbes; 2014; 5(1):15-27. PubMed ID: 24253566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
